Skip to main content
Log in

Clinical guidelines

Secondary prevention of gastric cancer

  • News & Views
  • Published:

From Nature Reviews Gastroenterology & Hepatology

View current issue Sign up to alerts

The natural history of 'epidemic' intestinal-type gastric cancer provides consistent data that enable clinicians to design multidisciplinary strategies for secondary prevention. A recent paper by Dinis-Ribeiro et al. reports guidelines for the management of patients with precancerous stomach lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: The OLGA staging systems frame.

References

  1. Correa, P., Haenszel, W., Cuello, C., Tannenbaum, S. & Archer, M. A model for gastric cancer epidemiology. Lancet 2, 58–60 (1975).

    Article  CAS  PubMed  Google Scholar 

  2. Marshall, B. J. & Warren, J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311–1315 (1984).

    Article  CAS  PubMed  Google Scholar 

  3. Graham, D. Y. & Rugge, M. Clinical practice: diagnosis and evaluation of dyspepsia. J. Clin. Gastroenterol. 44, 167–172 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Graham, D. Y. & Asaka, M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J. Gastroenterol. 45, 1–8 (2010).

    Article  PubMed  Google Scholar 

  5. Dinis-Ribeiro, M. et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 44, 74–94 (2012).

    Article  CAS  PubMed  Google Scholar 

  6. Rugge, M. et al. Gastritis: the histology report. Dig. Liver Dis. 43 (Suppl. 4), S373–S384 (2011).

    Article  PubMed  Google Scholar 

  7. Agréus, L. et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand. J. Gastroenterol. 47, 136–147 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Price, A. B. The Sydney System: histological division. J. Gastroenterol. Hepatol. 6, 209–222 (1991).

    Article  CAS  PubMed  Google Scholar 

  9. Rugge, M. et al. OLGA staging for gastritis: a tutorial. Dig. Liver Dis. 40, 650–658 (2008).

    Article  CAS  PubMed  Google Scholar 

  10. Rugge, M. et al. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J. Gastroenterol. 17, 4596–4601 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Massimo Rugge.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rugge, M., Fassan, M. & Graham, D. Secondary prevention of gastric cancer. Nat Rev Gastroenterol Hepatol 9, 128–129 (2012). https://doi.org/10.1038/nrgastro.2012.19

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2012.19

  • Springer Nature Limited

This article is cited by

Navigation